Review Article

Phage-Based Artificial Niche: The Recent Progress and Future Opportunities in Stem Cell Therapy

Table 1

Engineered M13 phage-based artificial cell niches.

SNPeptide sequence expressedProgenitor/stem cellInfluence on cell fateReferences

1PDPLEPRREVCE and YGFGGMSCMorphology, proliferation, and differentiation of MSC is enhancedZhu et al. [127]
2RGD and PHSRNMSCOsteoblastic differentiation of MSC without osteogenic supplementsWang et al. [128]
3RGD, PHSRN, ALKRQGRTLYGFGG, and KIPKASSSVPTELSAISTLYLiPSCDifferentiation into osteoblasts in the absence of osteogenic supplementsWang et al. [129]
4RGDMSCVascularized osteogenesis in 3D-printed bone scaffoldsWang et al. [130]
5RGD and SDKPECInduced angiogenesis by recruiting and activating EC; potential to restore tissues after ischemic injuryYoo et al. [131]
6RGD and IKVAVNPCFavorable substrates for NPC proliferation and differentiationMerzlyak et al. [132]
7RGD and HPQMC3T3, ASCStiffness platform for modulating cell expansion and differentiationLee et al. [144]
8RGD and HPQNPCSynergistic roles of immobilized growth factor and phage in controlling NPC morphology and growthYoo et al. [147]
9DGEAMC3T3Early osteogenic differentiation of mouse preosteoblasts MC3T3Yoo et al. [148]
10RGDNPCEnhanced directional proliferation and differentiation of NPCChung et al. [150]
11RGD and DDYPMC3T3Biomimetic nanoink showed enhanced proliferation and differentiationLee et al. [156]

EC: endothelial cells; iPSC: induced pluripotent stem cells; NPC: neural progenitor cells; MSC: mesenchymal stem cells; ASC: adipose-derived stem cells; MC3T3: preosteoblast cells.